investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Characterization of breast cancer dormancy in bone
Rachelle W Johnson
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Jack Martin
St Vincents Institute of Medical Research
Fitzroy, Australia
Peter Croucher
Garvan Institute of Medical Research
Darlinghurst, Australia
Rachelle W Johnson
Stanford University
Stanford, United States
Related projects
Elena N Pugacheva
The Role of HEF1 Protein in Division and Invasion of Metastatic Breast Cancer
Breast
Amato J Giaccia
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Breast
Radiation Oncology
Scott I Abrams
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
Breast
Calvin J Kuo
miR-126 Regulation of Tumor Progression
Breast
Ann Marie Pendergast
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
Breast
Andrea Hope Bild
Integrative signaling models to decipher complex cancer phenotypes
Breast
Neil Johnson
Identifying BRCA1 protein variants that provide resistance to therapy
Breast
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Breast
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast